Biocon submits press release

22 Aug 2019

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Biocon has informed about submission of the press release titled ‘Biocon’s Malaysia Insulin Glargine Manufacturing Facility Receives EU GMP Certification, Provides Fillip to its Capacity’. The above information will also be available on the website of the Company at www.biocon.com.  

The above information is a part of company’s filings submitted to BSE.

Related Biocon Ltd. Links:

Biocon Share Price

393.40 -0.90 (-0.23%) Mar 08, 18:37
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 614.85
Dr. Reddys Lab 4490.20
Lupin 1050.45
Piramal Enterprises 1917.10
Cadila Healthcare 446.10
View more..
Sensex vs Biocon
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback